Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $174,983,383 across 5 holdings for the quarter ended 2023-03-31, in a 13F-HR filed 2023-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-23-060801

Period
2023-03-31
Reported value
$175M
Holdings
5
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BERKELEY LTS INCnew+5,390,820$6.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ISOPLEXIS CORPexited-8,808,531-$13.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2023

Share positions as resolved from 13F-HR 0001104659-23-060801, largest first. % of portfolio is the value over $174,983,383, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DICE THERAPEUTICS INCDICE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 3,292,871 shares; 2023Q1: 3,292,871 shares 3,292,871$94.3M53.91%0
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 4,214,498 shares; 2023Q1: 4,214,498 shares 4,214,498$41.3M23.58%0
CODEX DNA INCCODEX DNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 9,844,130 shares; 2023Q1: 9,844,130 shares 9,844,130$30.5M17.44%0
BERKELEY LTS INCBERKELEY LTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: 5,390,820 shares 5,390,820$6.25M3.57%new
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,935,215 shares; 2023Q1: 1,935,215 shares 1,935,215$2.61M1.49%0Timeline

Sold out in Q1 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ISOPLEXIS CORPISOPLEXIS CORP8,808,531$13.7Mshares

How Q1 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-060801 base2023-05-15acceptance time not in the bulk data set